Santos-Sánchez, G.; Álvarez-López, A.I.; Ponce-España, E.; Álvarez-Ríos, A.I.; Lardone, P.J.; Carrillo-Vico, A.; Cruz-Chamorro, I.
Melatonin Modulates Lipid Metabolism and Reduces Cardiovascular Risk in Apolipoprotein E-Deficient Mice Fed a Western Diet. Nutraceuticals 2024, 4, 260-272.
https://doi.org/10.3390/nutraceuticals4020016
AMA Style
Santos-Sánchez G, Álvarez-López AI, Ponce-España E, Álvarez-Ríos AI, Lardone PJ, Carrillo-Vico A, Cruz-Chamorro I.
Melatonin Modulates Lipid Metabolism and Reduces Cardiovascular Risk in Apolipoprotein E-Deficient Mice Fed a Western Diet. Nutraceuticals. 2024; 4(2):260-272.
https://doi.org/10.3390/nutraceuticals4020016
Chicago/Turabian Style
Santos-Sánchez, Guillermo, Ana Isabel Álvarez-López, Eduardo Ponce-España, Ana Isabel Álvarez-Ríos, Patricia Judith Lardone, Antonio Carrillo-Vico, and Ivan Cruz-Chamorro.
2024. "Melatonin Modulates Lipid Metabolism and Reduces Cardiovascular Risk in Apolipoprotein E-Deficient Mice Fed a Western Diet" Nutraceuticals 4, no. 2: 260-272.
https://doi.org/10.3390/nutraceuticals4020016
APA Style
Santos-Sánchez, G., Álvarez-López, A. I., Ponce-España, E., Álvarez-Ríos, A. I., Lardone, P. J., Carrillo-Vico, A., & Cruz-Chamorro, I.
(2024). Melatonin Modulates Lipid Metabolism and Reduces Cardiovascular Risk in Apolipoprotein E-Deficient Mice Fed a Western Diet. Nutraceuticals, 4(2), 260-272.
https://doi.org/10.3390/nutraceuticals4020016